|
WO2021060862A1
|
|
Pharmaceutical composition for preventing or treating malaria, containing fucoidan as active ingredient
|
|
KR20210030883A
|
|
Marker comprising Indoleamine-2,3-dioxygenase for diagnosing of prostate cancer
|
|
WO2021045591A1
|
|
Oxanine nucleobase-mediated dna ligation method
|
|
WO2021045568A1
|
|
Carbon dioxide reducing photocatalyst and preparation method therefor, and carbon dioxide reducing method
|
|
KR20200107902A
|
|
Etching apparatus and etching method using the same
|
|
KR20210028587A
|
|
AED based on Augmented Reality
|
|
WO2021040349A1
|
|
Novel hepsin inhibitor and pharmaceutical composition comprising same as effective component for preventing or treating metastatic cancer
|
|
WO2021040333A1
|
|
Composition for preventing or treating bacterial infectious disease comprising 4-gingerol derivative compound as active ingredient
|
|
KR20210011343A
|
|
Antiviral composition for Zika virus comprising lipophilic statins
|
|
KR20200088242A
|
|
Organic-inorganic hybrid thin-film silicon solar cells, and method of manufacturing the same
|
|
KR20200145777A
|
|
Nucleobase-involved native chemical ligation for novel oligonucleotide-peptide conjugation
|
|
KR20200135191A
|
|
Novel EctP1-peptide tag and method for immobilization or purification of recombinant proteins using thereof
|
|
WO2020165883A2
|
|
Novel peptide for silica synthesis and method for synthesizing silica particles using same
|
|
US2020261593A1
|
|
Linker composition comprising silica-forming peptides
|
|
KR20200100543A
|
|
Novel silica forming peptides, and Method for manufacturing silica particles using the same
|
|
KR20200099976A
|
|
Linker composition comprising silica-forming peptides
|
|
KR20200115061A
|
|
Thin film transistor and manufacturing method thereof
|
|
WO2020241999A1
|
|
Affinity separation system and method using switch-like adhesion reaction
|
|
WO2020130703A2
|
|
Stretchable display
|
|
KR20200077402A
|
|
Stretchable display
|
